OBJECTIVES: To estimate caretaker adherence to co-blistered, but not co-formulated, artesunate-amodiaquine (AsAq) for uncomplicated malaria and identify factors associated with caretaker adherence. METHODS: Cross sectional household survey of caretakers of 210 children under 5 years of age who had been prescribed and dispensed AsAq at 21 public health facilities (HFs). The caretakers were interviewed in their homes on the 4th day of receiving the 3 day treatment. Adherence of caretakers was assessed by self report and pill count. RESULTS: Caretaker adherence to AsAq was 77% (95% CI: 67%-87%). Non-adherence resulted in under-dosing (3/4) of the time and was most often in the form of wrong daily doses due to misunderstanding or forgetting the correct dose regimens. Predictors of adherence were education exceeding 7 years (OR = 5.08, P = 0.008) and receiving the exact number of pills to complete the treatment regimen (OR = 4.09, P = 0.006). All caretakers of children who were administered the first dose at the HF had adhered to the treatment. CONCLUSION: We found moderate levels of caretaker adherence to AsAq. Further improvement could be achieved by producing dose-specific packaging for infants, providing clear instructions and giving the first dose under observation at the HF.
OBJECTIVES: To estimate caretaker adherence to co-blistered, but not co-formulated, artesunate-amodiaquine (AsAq) for uncomplicated malaria and identify factors associated with caretaker adherence. METHODS: Cross sectional household survey of caretakers of 210 children under 5 years of age who had been prescribed and dispensed AsAq at 21 public health facilities (HFs). The caretakers were interviewed in their homes on the 4th day of receiving the 3 day treatment. Adherence of caretakers was assessed by self report and pill count. RESULTS: Caretaker adherence to AsAq was 77% (95% CI: 67%-87%). Non-adherence resulted in under-dosing (3/4) of the time and was most often in the form of wrong daily doses due to misunderstanding or forgetting the correct dose regimens. Predictors of adherence were education exceeding 7 years (OR = 5.08, P = 0.008) and receiving the exact number of pills to complete the treatment regimen (OR = 4.09, P = 0.006). All caretakers of children who were administered the first dose at the HF had adhered to the treatment. CONCLUSION: We found moderate levels of caretaker adherence to AsAq. Further improvement could be achieved by producing dose-specific packaging for infants, providing clear instructions and giving the first dose under observation at the HF.
Authors: Raymond K Sudoi; Sophie Githinji; Andrew Nyandigisi; Alex Muturi; Robert W Snow; Dejan Zurovac Journal: Malar J Date: 2012-02-08 Impact factor: 2.979
Authors: Beth P Kangwana; Sarah V Kedenge; Abdisalan M Noor; Victor A Alegana; Andrew J Nyandigisi; Jayesh Pandit; Greg W Fegan; James E Todd; Simon Brooker; Robert W Snow; Catherine A Goodman Journal: PLoS Med Date: 2011-05-31 Impact factor: 11.069
Authors: Dejan Zurovac; Raymond K Sudoi; Willis S Akhwale; Moses Ndiritu; Davidson H Hamer; Alexander K Rowe; Robert W Snow Journal: Lancet Date: 2011-08-03 Impact factor: 79.321
Authors: Harriet Lawford; Dejan Zurovac; Laura O'Reilly; Sarah Hoibak; Alice Cowley; Stephen Munga; John Vulule; Elizabeth Juma; Robert W Snow; Richard Allan Journal: Malar J Date: 2011-09-23 Impact factor: 2.979
Authors: Lucy A Smith; Caroline Jones; Rose O Adjei; Gifty D Antwi; Nana A Afrah; Brian Greenwood; Daniel Chandramohan; Harry Tagbor; Jayne Webster Journal: Malar J Date: 2010-01-14 Impact factor: 2.979
Authors: Joan N Kalyango; Elizeus Rutebemberwa; Charles Karamagi; Edison Mworozi; Sarah Ssali; Tobias Alfven; Stefan Peterson Journal: PLoS One Date: 2013-03-29 Impact factor: 3.240